Karuna Therapeutics Inc reports results for the quarter ended in March - Earnings Summary

Karuna Therapeutics

05/05/2022 21:40

* Karuna Therapeutics Inc  KRTX.OQ  reported a quarterly
adjusted
loss of $1.95​​ per share for the quarter ended in March. The
mean expectation of fourteen analysts for the quarter was for a
loss of $2.11 per share.
    * Reported revenue was zero​;  analysts expected zero. 
    * Karuna Therapeutics Inc's reported EPS for the quarter was
a
loss of $1.95​.
    * The mean earnings estimate of analysts had fallen by
about 4.1%
in the last three months.​ 
    * In the last 30 days one analyst negatively revised an
earnings
estimate 
    * Karuna Therapeutics Inc shares had fallen by 3.6% this
quarter and lost 6.7% so far this year.
    * The company reported a quarterly loss of $58.22 million.
    * Wall Street's median 12-month price target for Karuna
Therapeutics Inc is $180.50 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 17 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated May 5 at 08:40 p.m.  ​All
figures in US dollars unless otherwise stated